Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Open accessPublished version of a preprint
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
COVID‐19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD + ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID‐19 patients. CMAs include l ‐serine, N ‐acetyl‐ l ‐cysteine, nicotinamide riboside, and l ‐carnitine tartrate, salt form of l ‐carnitine. Placebo‐controlled, open‐label phase 2 study and double‐blinded phase 3 clinical trials are conducted to investigate the time of symptom‐free recovery on ambulatory patients using CMAs. The results of both studies show that the time to complete recovery is significantly shorter in the CMA group (6.6 vs 9.3 d) in phase 2 and (5.7 vs 9.2 d) in phase 3 trials compared to placebo group. A comprehensive analysis of the plasma metabolome and proteome reveals major metabolic changes. Plasma levels of proteins and metabolites associated with inflammation and antioxidant metabolism are significantly improved in patients treated with CMAs as compared to placebo. The results show that treating patients infected with COVID‐19 with CMAs lead to a more rapid symptom‐free recovery, suggesting a role for such a therapeutic regime in the treatment of infections leading to respiratory problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, patients treated with CMAs showed significant improvements in plasma levels of several inflammation and antioxidant metabolism-related biomarkers, such as alanine aminotransferase (ALT), lactate dehydrogenase (LDH), creatinine, glucose, and proteins [109].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CMAs were found to reinforce immune response and regulate amino acid and lipid metabolism.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study showed that combined metabolic activators (CMAs), consisting of NR (1 g), l-carnitine tartrate (3.73 g), N-acetylcysteine (2.55 g), and serine (12.35 g), improved the COVID-19 outcomes.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [109]
The cited source says what the claim attributes to it.
In the citing paper
“In both a placebo-controlled, open-label phase 2 study and double-blinded phase 3 clinical trials, patients given CMAs had significantly faster complete recovery times compared to the placebo group (6.6 vs 9.3 days and 5.7 vs 9.2 days, respectively).”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
Zhu, L., She, Z.-G., Cheng, X., Qin, J.-J., Zhang, X.-J., Cai, J., Lei, F., Wang, H., Xie, J., Wang, W., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.021 · Cited by 1,602
Self-citationProteomic and Metabolomic Characterization of COVID-19 Patient Sera
Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.032 · Cited by 1,514
Self-citationHung, I. F.-N., Lung, K.-C., Tso, E. Y.-K., Liu, R., Chung, T. W.-H., Chu, M.-Y., Ng, Y.-Y., Lo, J., Chan, J., Tam, A. R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31042-4 · Cited by 1,455
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697
Serine is an essential metabolite for effector T cell expansion
Ma, E. H., Bantug, G., Griss, T., Condotta, S., Johnson, R. M., Samborska, B., Mainolfi, N., Suri, V., Guak, H., Balmer, M. L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.011 · Cited by 657
Research works printed but not linked: 3
- Thomas T., 2020, JCI Insight, 5
- Hundt M. A., 2020, Hepatology
- 10.1038/pr.2013.71 · DOI
Cited by
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
Advances and Utility of the Human Plasma Proteome
Deutsch, E. W., Omenn, G. S., Sun, Z., Maes, M., Pernemalm, M., Palaniappan, K. K., Letunica, N., Vandenbrouck, Y., Brun, V., Tao, S.-C., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00657 · Cited by 246
Pleiotropic effects of mitochondria in aging
Lima, T., Li, T. Y., Mottis, A., & Auwerx, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00191-2 · Cited by 236
Therapeutic application of natural products: NAD+ metabolism as potential target
Guo, C., Huang, Q., Wang, Y., Yao, Y., Li, J., Chen, J., Wu, M., Zhang, Z., Mingyao, E., Qi, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154768 · Cited by 127
Self-citationWhat is really known about the effects of nicotinamide riboside supplementation in humans
Damgaard, M. V., & Treebak, J. T. (2023) · Science Advances · doi:10.1126/sciadv.adi4862 · Cited by 113
Okabe, K., Yaku, K., Uchida, Y., Fukamizu, Y., Sato, T., Sakurai, T., Tobe, K., & Nakagawa, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.868640 · Cited by 105
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 97
A Global Picture: Therapeutic Perspectives for COVID-19
Chavda, V. P., Kapadia, C., Soni, S., Prajapati, R., Chauhan, S. C., Yallapu, M. M., & Apostolopoulos, V. (2022) · Immunotherapy · doi:10.2217/imt-2021-0168 · Cited by 95
Freeberg, K. A., Udovich, C. C., Martens, C. R., Seals, D. R., & Craighead, D. H. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad106 · Cited by 81
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00336-2 · Cited by 79
Self-citationWong, K. K., Lee, S. W. H., & Kua, K. P. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s306849 · Cited by 65
D’Alessandro, A., Akpan, I. J., Thomas, T., Reisz, J. A., Cendali, F. I., Gamboni, F., Nemkov, T. G., Thangaraju, K., Katneni, U., Tanaka, K. A., et al. (2021) · Cells · doi:10.3390/cells10092293 · Cited by 60
NAD+ metabolism-based immunoregulation and therapeutic potential
Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., Shi, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01031-5 · Cited by 61
Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
Matsuyama, T., Yoshinaga, S. K., Shibue, K., & Mak, T. W. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00892-y · Cited by 59
Pencina, K. M., Lavu, S., dos Santos, M. R., Beleva, Y. M., Cheng, M. S., Livingston, D. H., & Bhasin, S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac049 · Cited by 56
Genome-scale models in human metabologenomics
Mardinoglu, A., & Palsson, B. Ø. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-024-00768-0 · Cited by 54
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 54
Isman, A., Nyquist, A., Strecker, B., Harinath, G., Lee, V., Zhang, X., & Zalzala, S. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100733 · Cited by 54
Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics
Wang, Y., Zhang, H., & Miao, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07714-w · Cited by 50
NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies
Chen, C., Yan, W., Tao, M., & Fu, Y. (2023) · Antioxidants · doi:10.3390/antiox12061230 · Cited by 49
Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
Zhong, W., Altay, Ö., Arif, M., Edfors, F., Doğanay, H. L., Mardinoğlu, A., Uhlén, M., & Fagerberg, L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103723 · Cited by 48
Self-citationBadawy, A. A. ‐. (2023) · Bioscience Reports · doi:10.1042/bsr20230595 · Cited by 44
Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease
Zeybel, M., Altay, Ö., Arif, M., Li, X., Yang, H., Fredolini, C., Akyıldız, M., Sağlam, B., Gönenli, M. G., Ural, D., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110459 · Cited by 44
Self-citationViral infection as an NAD+ battlefield
Brenner, C. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00507-3 · Cited by 41
The role of antigen-presenting cells in the pathogenesis of COVID-19
Farzi, R., Aghbash, P. S., Eslami, N., Azadi, A., Shamekh, A., Hemmat, N., Entezari‐Maleki, T., & Baghi, H. B. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153848 · Cited by 36
NAD + Precursors in Human Health and Disease: Current Status and Future Prospects
Yaku, K., & Nakagawa, T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0354 · Cited by 33
Kishk, A., Pacheco, M. P., & Sauter, T. (2021) · iScience · doi:10.1016/j.isci.2021.103331 · Cited by 28
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics
Wais, T., Hasan, M., Rai, V., & Agrawal, D. K. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2105697 · Cited by 26
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
du Preez, H. N., Aldous, C. M., Kruger, H. G., & Lin, J. (2022) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2022/4555490 · Cited by 25
Páez-Franco, J. C., Maravillas‐Montero, J. L., Mejía‐Domínguez, N. R., Torres-Ruiz, J. J., Tamez-Torres, K. M., Pérez‐Fragoso, A., Germán-Acacio, J. M., Ponce‐de‐León, A., Gómez‐Martín, D., & Ulloa‐Aguirre, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274910 · Cited by 24
Panahi, Y., Ghanei, M., Rahimi, M., Samim, A., Vahedian‐Azimi, A., Atkin, S. L., & Sahebkar, A. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28393 · Cited by 24
The acute effect of different NAD+ precursors included in the combined metabolic activators
Li, X., Yang, H., Jin, H., Türkez, H., Öztürk, G., Doğanay, H. L., Zhang, C., Nielsen, J., Uhlén, M., Borén, J., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.032 · Cited by 25
Self-citationEmerging Role of Nicotinamide Riboside in Health and Diseases
Sharma, C., Donu, D., & Cen, Y. (2022) · Nutrients · doi:10.3390/nu14193889 · Cited by 24
Barlattani, T., Celenza, G., Cavatassi, A., Minutillo, F., Socci, V., Pinci, C., Santini, R., & Pacitti, F. (2024) · Current Neuropharmacology · doi:10.2174/011570159x343115241030094848 · Cited by 23
Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19
Bogan-Brown, K. L., Nkrumah-Elie, Y. M., Ishtiaq, Y., Redpath, P., & Shao, A. E. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1881686 · Cited by 22
Tilinca, M. C. (2021) · FARMACIA · doi:10.31925/farmacia.2021.4.2 · Cited by 21
Wu, C., Reynolds, W. C., Abril, I., McManus, A. J., Brenner, C., González-Irizarry, G., Gutiérrez-Martínez, L., Sun, O., Rosand, J. M., Tanzi, R. E., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103633 · Cited by 19
Acute exercise boosts NAD+ metabolism of human peripheral blood mononuclear cells
Walzik, D., Joisten, N., Schenk, A., Trebing, S., Schaaf, K., Metcalfe, A. J., Spiliopoulou, P., Hiefner, J., McCann, A., Watzl, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.004 · Cited by 18
Bolesławska, I., Kowalówka, M., Bolesławska-Król, N., & Przysławski, J. (2023) · Viruses · doi:10.3390/v15061262 · Cited by 18
Block, T., & Kuo, J. C. (2022) · Clinical Pathology · doi:10.1177/2632010x221106986 · Cited by 18
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19
Barthez, M., Xue, B., Zheng, J., Wang, Y., Song, Z., Mu, W., Wang, C.-L., Guo, J., Yang, F., Ma, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115562 · Cited by 16
Honarmand, K., Penn, J. B., Agarwal, A., Siemieniuk, R. A. C., Brignardello‐Petersen, R., Bartoszko, J. J., Zeraatkar, D., Agoritsas, T., Burns, K. E. A., Fernando, S. M., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.07.002 · Cited by 16
Yang, H., Mayneris‐Perxachs, J., Boqué, N., Bas-Prior, J. M. D., Arola, L., Yuan, M., Türkez, H., Uhlén, M., Borén, J., Zhang, C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101440 · Cited by 16
Self-citationExploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Halma, M. T. J., Marik, P. E., & Saleeby, Y. M. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100163 · Cited by 14
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases
Branch of Cardiovascular Physicians of Chinese Medical Doctor Association (2023) · Cardiology Plus · doi:10.1097/cp9.0000000000000043 · Cited by 13
Freeberg, K. A., Ludwig, K. R., Chonchol, M., Seals, D. R., & Rossman, M. J. (2023) · Nitric Oxide · doi:10.1016/j.niox.2023.08.003 · Cited by 13
Modeling for understanding and engineering metabolism
Nielsen, J., & Petranović, D. (2025) · QRB Discovery · doi:10.1017/qrd.2025.1 · Cited by 13
Self-citationLong, Q., Song, S., Xue, J., Yu, W., Zheng, Y., Li, J., Wu, J., Hu, X., Jiang, M., Ye, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1577803 · Cited by 12
Ni, F.-D., Wang, F., Li, J., Liu, Y., Sun, X., Chen, J., Li, J., Zhang, Y., Jin, J., Ye, X., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad168 · Cited by 12
Yuluğ, B., Altay, Ö., Li, X., Hanoğlu, L., Çankaya, Ş., Velioğlu, H. A., Lam, S., Yang, H., Coşkun, E., İdil, E., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae478 · Cited by 11
Self-citationUrine Metabolites Enable Fast Detection of COVID-19 Using Mass Spectrometry
Moura, A. V., de Oliveira, D. C., Silva, A., da Rosa, J. R., Garcia, P. H. D., Sanches, P. H. G., Garza, K. Y., Mendes, F. M. M., Lambert, M., Marrero-Gutiérrez, J., et al. (2022) · Metabolites · doi:10.3390/metabo12111056 · Cited by 11
Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID ‐19
Valderrábano, R. J., Wipper, B., Pencina, K. M., Migaud, M. E., Shang, Y. V., Latham, N. K., Montano, M. A., Cunningham, J. M., Wilson, L., Peng, L., et al. (2024) · Aging Cell · doi:10.1111/acel.14326 · Cited by 10
Türkez, H., Altay, Ö., Yıldırım, S., Li, X., Yang, H., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121325 · Cited by 10
Self-citationRetractedLu, Y. P., Xu, S., Sun, H., Shan, J., Shen, C., Ji, J., Lin, L., Xu, J., Peng, L., Dai, C., et al. (2023) · Metabolomics · doi:10.1007/s11306-023-01991-2 · Cited by 9
Talebi, S. S., Ghasemi, M., Esfahani, M. E., Mohammadi, Y., & Haddadi, R. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00402-y · Cited by 9
Total network controllability analysis discovers explainable drugs for Covid-19 treatment
Wei, X., Pan, C., Zhang, X., & Zhang, W. (2023) · Biology Direct · doi:10.1186/s13062-023-00410-9 · Cited by 9
Altay, Ö., Yang, H., Yıldırım, S., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., Hacımüftüoğlu, A., Shoaie, S., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12040927 · Cited by 9
Self-citationYang, H., Li, X., Jin, H., Türkez, H., Öztürk, G., Doğanay, H. L., Zhang, C., Nielsen, J., Uhlén, M., Borén, J., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.013 · Cited by 8
Self-citationDifferences in Extracellular NAD+ and NMN Metabolism on the Surface of Vascular Endothelial Cells
Jabłońska, P., Mierzejewska, P., Tomczyk, M., Koszałka, P., Frańczak, M., Kawecka, A., Kutryb-Zając, B. A., Braczko, A., Smolenski, R. T., & Slominska, E. M. (2022) · Biology · doi:10.3390/biology11050675 · Cited by 8
Schuller, M., Oberhuber, M., Prietl, B., Zügner, E., Prugger, E.-M., Magnes, C., Kirsch, A. H., Schmaldienst, S., Pieber, T. R., Brodmann, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214089 · Cited by 8
Combined Metabolic Activators Improves Cognitive Functions in Alzheimer's DiseasePreprint
Yuluğ, B., Altay, Ö., Li, X., Hanoğlu, L., Çankaya, Ş., Lam, S. C. C., Yang, H., Coşkun, E., İdil, E., Nogaylar, R., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3924201 · Cited by 8
Self-citationYuluğ, B., Altay, Ö., Li, X., Hanoğlu, L., Çankaya, Ş., Lam, S. C. C., Yang, H., Coşkun, E., İdil, E., Nogaylar, R., et al. (2021) · medRxiv · doi:10.1101/2021.07.28.21261293 · Cited by 8
Self-citationIntegration of protein context improves protein-based COVID-19 patient stratification
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Yi, X., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09370-0 · Cited by 6
Hoang, B. X., HAN, B., FANG, W. H., NGUYEN, A. K., Shaw, D. G., Hoang, C., & Tran, H. D. (2023) · In Vivo · doi:10.21873/invivo.13224 · Cited by 6
Badaró, R. J. D. S., Barbosa, J. D. V., Neto, C. A. D. A., Machado, B. A. S., Soares, M. B. P., de Senna, V., Taddeo, M. M., de Araújo, L. T., Durkee, S., Donninger, R., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1134162 · Cited by 5
Kazmi, N., Smith, G. D., & Lewis, S. J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3857663 · Cited by 5
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy
Song, S., Gan, J., Long, Q., Gao, Z., & Zheng, Y. (2024) · Vaccines · doi:10.3390/vaccines13010001 · Cited by 4
Machine learning identifies proteomic risk factors across 23 diseases
Meng, L., Li, M., Kong, X., Zhang, T., Álvez, M. B., Liao, X., Türkez, H., Altay, Ö., Zhang, C., Uhlén, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114687 · Cited by 4
Self-citationCLINICAL MANAGEMENT OF PATIENTS WITH COVID-19. “LIVE” CLINICAL INSTRUCTION (2021)
Дмитрівна, С. І. (2021) · ДЕРЖАВНА НАУКОВА УСТАНОВА «НАУКОВО-ПРАКТИЧНИЙ ЦЕНТР ПРОФІЛАКТИЧНОЇ І КЛІНІЧНОЇ МЕДИЦИНИ» eBooks · doi:10.31612/covid · Cited by 4
Immune status assessment based on plasma proteomics with meta graph convolutional networks
Zhang, M., Xu, N., Cheng, Q., Ye, J., Wu, S., Liu, H., Zhao, C., Yu, L., & Feng, W. (2025) · BMC Genomics · doi:10.1186/s12864-025-11537-6 · Cited by 3
Türkez, H., Arslan, M. E., Selvitopi, H., Kadı, A., Öner, S., & Mardinoğlu, A. (2023) · Medicina · doi:10.3390/medicina60010082 · Cited by 3
Pencina, K. M., Leaf, D. E., Valderrábano, R. J., Waikar, S. S., Mehta, T. S., Shang, Y. V., Latham, N. K., John, T., Volpi, E., Fusco, D. N., et al. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00014 · Cited by 3
Colgan, D. D., Stadler, D. D., Hope, A. A., Zwickey, H. L., Davenport, T. E., & Weimbs, T. (2025) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2025.148052 · Cited by 2
Targeting mitochondrial metabolism with combined metabolic activators
Yang, H., Kong, X., Liao, X., Türkez, H., Borén, J., Uhlén, M., Altay, Ö., & Mardinoğlu, A. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.01.018 · Cited by 2
Self-citationCeyhan, A. B., Kaynar, A., Altay, Ö., Zhang, C., Temel, Ş. G., Türkez, H., & Mardinoğlu, A. (2024) · Biomolecules · doi:10.3390/biom14111376 · Cited by 2
Self-citationNaeimzadeh, F., Sadeghi, A., Saghaleini, S. H., Sarbakhsh, P., Mahmoodpoor, A., & Gharekhani, A. (2024) · Bioimpacts · doi:10.34172/bi.2024.30261 · Cited by 1
Varikasuvu, S. R., Munikumar, M., Kumar, S., Mudgal, S. K., Raj, V., Varshney, S., Gupta, P., Grover, A., Goyal, C., Lal, V., et al. (2025) · Cellular and Molecular Biology · doi:10.14715/cmb/2025.71.5.13 · Cited by 1
Hrebenyk, M. V., Maslii, S., Shevchuk, O., Komorovsky, R., & Korda, M. M. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s527151 · Cited by 1
Sevim, Y., Arslan, M. E., Düzgün, Z., Tozlu, Ö. Ö., Öner, S., Kadı, A., & Türkez, H. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70681 · Cited by 1
Novel antioxidant protein target therapy to counter the prevalence and severity of SARS-CoV-2
Kaur, P., Dey, A., Rawat, K., & Dey, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1241313 · Cited by 1
Chen, W., Jiang, S., Li, C., Shu, L., Wang, J., & Xu, R. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1417183 · Cited by 1
Recent advances in nutritional metabolism studies on SARS-CoV-2 infection
Jiang, Y., Li, X., Zheng, X., & Shi, H. (2025) · Infectious Medicine · doi:10.1016/j.imj.2025.100162 · Cited by 1
Self-citationTotal controllability analysis discovers explainable drugs for Covid-19 treatmentPreprint
Wei, X., Pan, C., Zhang, X., & Zhang, W. (2022) · arXiv (Cornell University) · doi:10.48550/arxiv.2206.02970 · Cited by 1
Proteomic Investigation of COVID-19 Severity During the Tsunamic Second Wave in Mumbai
Rajoria, S., Nair, D., Suvarna, K., Pai, M. G. J., Salkar, A., Palanivel, V., Verma, A., Barpanda, A., Awasthi, G., Doshi, H., et al. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-28012-2_9
Examples for successful commercial production of plant-derived bioactive compounds
Qu, L., Deng, J., & Fan, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15584-0.00003-3
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Xiao, Y., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479632
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Xiao, Y., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479626
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Yi, X., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479629
The Application of Nicotinamide Coenzyme Precursors in Health Food
Feng, Z.-Y., She, J., Qin, Z., & Sheng, R. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_47
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Yi, X., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479623
Gao, J., He, J., Zhang, F., Xiao, Q., Cai, X., Yi, X., Zheng, S., Zhang, Y., Wang, D., Zhu, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20479620
Mapping the Metabolism of Coronavirus Infection: Insights from Cell Culture Metabolomics
Wildman, S. (2022) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/dspace/41358
Freeberg, K. A. (2023) · CU Scholar (University of Colorado Boulder)
İnflamatuvar hastalıklarda varyant belirlenmesi
Alkurt, G. (2024) · Istanbul Technical University Academic Open Archive (Istanbul Technical University)
Self-citationNordic track: NIH dysfunction and my Helsinki recruitment
Brenner, C. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.06.003
NAD⁺ biology and supplementation: From mechanisms to clinical perspectives
Pandolfi, S., Ghezzi, C., Bjørklund, G., Metalla, M., Paone, F. M., & Chirumbolo, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12351-3
Targeting Immunomodulation by Glutathione: A Possible Therapeutic Strategy against COVID-19
Yiannakopoulou, E. C. (2026) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303400155251202063218
Metadata
- Authors
- Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., Turkez, H., Shoaie, S., Nielsen, J., Borén, J., Olmuscelik, O., Doganay, L., Uhlén, M., & Mardinoglu, A.
- Affiliations
- Science for Life Laboratory KTH—Royal Institute of Technology Stockholm SE‐100 44 Sweden
- Science for Life Laboratory (SE)
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- Department of Molecular Biology and Genetics Istanbul Technical University Istanbul 34469 Turkey
- Department of Medical Biology Faculty of Medicine Atatürk University Erzurum 25240 Turkey
- King's College London (GB)
- Chalmers University of Technology (SE)
- Sahlgrenska University Hospital (SE)
- Department of Internal Medicine Istanbul Medipol University Bagcılar Istanbul 34214 Turkey
- Department of Gastroenterology Umraniye Training and Research Hospital University of Health Sciences Istanbul 34766 Turkey
- ORCID
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2021-06-28
- Volume
- 8
- Issue
- 17
- Pages
- e2101222-e2101222
- ISSN
- 2198-3844 (ISSN-L)
- PMC
- PMC8420376
- OpenAlex
- W3174268490
- Cited by
- 88
- References
- 55
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 23 · 2022: 23 · 2021: 13
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Advanced Science (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Istanbul Technical University Academic Open Archive (Istanbul Technical University) (submittedVersion)
- Funders
- Knut och Alice Wallenbergs Stiftelse (20120)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, glutathione, NAD+ precursors, N-acetylcysteine, nicotinamide riboside, L-serine, plasma metabolome, plasma proteome, inflammation, antioxidant metabolism, metabolic therapy
- MeSH terms
- COVID-19, Adult, Aged, Antioxidants, Double-Blind Method, Female, Humans, Inflammation, Male, Middle Aged, Proteins, Proteome, Metabolome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.